Skip to main content

Table 7 VRK2 as independent marker in univariate and multivariate survival analysis in high-grade astrocytomas

From: VRK2 identifies a subgroup of primary high-grade astrocytomas with a better prognosis

 

Univariate analysis

Multivariate analysis

Parameter

HR (95% C.I.)

P value

HR (95% C.I.)

P value

VRK2 expression

1.80 (1.07 – 3.02)

0.025

2.10 (1.24 – 3.58)

0.006

Age (<60 vs. ≥ 60)

1.94 (1.15 – 3.26)

0.011

1.80 (1.06 – 3.05)

0.031

Treatment (Chemo + RT vs. RT alone vs. no treatment)

1.96 (1.22 – 3.15)

0.003

2.01 (1.22 – 3.30)

0.006

  1. HR: hazard ratio. RT: Radiotherapy. Chemo: Chemotherapy.